about
Caveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cellsCyclic motion encoding for enhanced MR visualization of slip interfacesMolecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular networkProstate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patientsRisk factors for prostate cancer incidence and progression in the health professionals follow-up studyMolecular Validation of PACE4 as a Target in Prostate CancerExpression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.Prostate-specific antigen testing of older men.Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer.The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patientsClinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging.PCR-free method detects high frequency of genomic instability in prostate cancer.Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study.Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.PREDICT: model for prediction of survival in localized prostate cancer.Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostateImmunophenotypic Characterization of Benign and Malignant Prostatic LesionsABC of urology. Article on prostate cancer should have adhered to agreed staging terminology.Decision analysis for treatment of early stage prostate cancer.Being on active surveillance: the patient perspective.
P2860
Q28476183-B270F6CD-4037-4996-8F7D-343B6C4DBFEFQ30481810-77911DCE-F629-4A0E-B092-B4590AFC31B5Q33677773-A96F4D04-DA45-48FD-915D-B528072333F9Q33698755-8A452036-57E1-4827-8C1B-FF32EB3BA48AQ33749037-625590E2-866A-42DA-91D1-D1AACE913CBDQ34621511-A38866F7-F065-4747-9494-45E24903A7CDQ35015483-1612F94E-C8E0-4643-B1A6-B5E7AA57BFFEQ35782407-B90453E3-4E44-4F47-947A-D275215D5A52Q36241844-ADBF4220-58E4-44D4-BD98-F983EF09A2CBQ36328850-5C8E68BE-FFC6-49C6-836E-174D8781190EQ36478226-3F6B34B3-3A0C-4941-AD54-86D7AA63792AQ36843615-8F56380E-1EF1-45D7-8ACC-3DE570DFD5AFQ36951975-0FF01E40-06C2-45AD-B063-ADEBA0D89CE9Q37404915-2C4FEB5F-EBF3-4127-B254-1D9503ACE7E1Q37477518-070016BE-FCC7-4C59-BE4B-CDD7BD2C6544Q39703942-92A64C8B-3EC9-49EA-8F95-86B8723CF46FQ39714383-57612E68-A4D2-4ABB-9FB9-C96C0EF5E8A5Q41288229-4E7DA94D-4159-449E-A8C6-C7931FA50C99Q41812715-023E7B9E-93C8-49F6-AC1B-CB6A26209017Q42146020-BADDEC4C-633E-45F1-91A0-7F47D6885E30Q42496163-41098DEA-5D52-49C2-9A4A-10AE5F986A1EQ43189267-A3FA2212-F05A-4938-8547-644C36E700F6Q47690542-B3F39958-93CC-4398-940F-088D3FB700D9Q55409616-0F3FDEAD-A705-4508-BBED-10DD675C28D7
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The TNM classification of prostate cancer.
@ast
The TNM classification of prostate cancer.
@en
type
label
The TNM classification of prostate cancer.
@ast
The TNM classification of prostate cancer.
@en
prefLabel
The TNM classification of prostate cancer.
@ast
The TNM classification of prostate cancer.
@en
P2093
P1476
The TNM classification of prostate cancer
@en
P2093
Gospodarowicz MK
Hermanek P
Pavone-Macaluso M
Schröder FH
P304
P577
1992-01-01T00:00:00Z